Parvovirus B19-antibody serosurvey in 500 developmentally disabled subjects.
Sera of 500 residents were screened for parvovirus B19 immunoglobulin M (IgM) and immunoglobulin G (IgG) by enzyme-linked immunosorbent assay. Positive IgM and equivocal IgG or IgM results were confirmed by immunofluorescent antibody and Western blot. IgM was detected in 13 sera (2.6%), and IgG was detected in 285 (57%). Records of IgM-positive residents contained no evidence of erythema infectiosum or polyarthropathy.
Lohiya
G S
GS
Fairview Developmental Center, Costa Mesa, CA 92626, USA.
Hogrefe
W
W
Tan-Figueroa
L
L
Caires
S
S
D000328:Adult; D000914:Antibodies, Viral / Q000097:blood; D002140:California / Q000453:epidemiology; D002648:Child; D003430:Cross-Sectional Studies; D002658:Developmental Disabilities / Q000150:complications*; D004197:Disease Reservoirs; D006306:Health Surveys; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D007075:Immunoglobulin M / Q000097:blood; D008297:Male; D008875:Middle Aged; D010322:Parvoviridae Infections / Q000453:epidemiology* / Q000276:immunology / Q000635:transmission; D016732:Parvovirus B19, Human / Q000276:immunology / Q000302:isolation & purification*; D011446:Prospective Studies; D012112:Residential Facilities; D012189:Retrospective Studies; D016036:Seroepidemiologic Studies; D013997:Time Factors
D000914:Antibodies, Viral; D007074:Immunoglobulin G; D007075:Immunoglobulin M